Hepatitis C News and Research

Latest Hepatitis C News and Research

Hepatitis C could become a rare disease by 2036

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the simulation are reported in the August 5 edition of the journal Annals of Internal Medicine.

5 Aug 2014

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.

5 Aug 2014

Viewpoints: Ignagni on prices of new drugs; Sen. Johnson on the difficulty of suing a president

Lately, there has been considerable debate about the soaring prices of specialty drugs, which are aimed at difficult-to-treat diseases.

5 Aug 2014

Medicaid roundup: Florida receives 3-year renewal for managed care program; Illinois limits Sovaldi

About 3 million Floridians are enrolled in the privatized program. Meanwhile, Illinois Medicaid puts limits on who is eligible for Sovaldi, an expensive hepatitis C drug, and Kansas recoups more than $28 million in Medicaid fraud.

5 Aug 2014

First Edition: August 4, 2014

Today's headlines include a variety of health policy stories reflecting developments on the state level.

4 Aug 2014

State highlights: Time of turmoil for Georgia hospitals; Oregon Medicaid takes aim at expensive heptatitis C drug

A selection of health policy stories from Gerogia, Wisconsin, Texas, Oregon, Florida, Michigan, Massachusetts, Connecticut and North Carolina.

4 Aug 2014

Medicare drug premiums to rise $1 a month in 2015

The modest increase of the monthly premium to $32 comes even as officials are concerned about the impact of expensive specialty drugs, such as Sovaldi, which cures hepatitis C but costs $1,000 a pill.

3 Aug 2014

Researchers one step closer to finding treatment for dengue fever

There have been several news reports that the world's first dengue vaccine will be available next year. However, the latest clinical trials show that the vaccine only provides a protection of around 50 per cent for DENV-2 and DENV-1, which are commonly found in Singapore.

1 Aug 2014

State highlights: Maryland's top health official leaving for Johns Hopkins; Minnesota lawmakers to propose legislation to require contraception coverage

Maryland's top health official, Joshua M. Sharfstein, announced Wednesday that he will leave at the end of Gov. Martin O'Malley's term in January to become an associate dean at the Johns Hopkins Bloomberg School of Public Health (Johnson, 7/30).

1 Aug 2014

Cigna's quarterly earnings up

Gains driven largely by global benefits operation after Cigna reported earlier that its business on the health law marketplaces was soft. News outlets also examine Humana and WellPoint's earnings.

31 Jul 2014

First Edition: July 31, 2014

Today's headlines include reports about the possible hazards that the future might hold for healthcare.gov.

31 Jul 2014

Several insurers report lower profits

WellPoint Inc. on Wednesday said its second-quarter profit slipped as the health insurer recorded higher expenses, masking a boost in revenue and enrollment.

31 Jul 2014

First Edition: July 30, 2014

Today's headlines include a range of health policy headines, including news from Capitol Hill on the Senate confirmation of Robert McDonald to head the VA.

30 Jul 2014

Conjoint Analysis method can show how important different treatment goals are for respondents

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues still need to be clarified.

30 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.

29 Jul 2014

New study in recognition of World Hepatitis Day released on Life Sciences Connect

The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.

28 Jul 2014

First Edition: July 28, 2014

Today's headlines include reports about the deal reached by House and Senate negotiators regarding veterans' health care.

28 Jul 2014

Researchers provide global genotype prevalence estimates for HCV

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

28 Jul 2014

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.

26 Jul 2014

Hepatitis C News and Research

Latest Hepatitis C News and Research

Hepatitis C could become a rare disease by 2036

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

Viewpoints: Ignagni on prices of new drugs; Sen. Johnson on the difficulty of suing a president

Medicaid roundup: Florida receives 3-year renewal for managed care program; Illinois limits Sovaldi

First Edition: August 4, 2014

State highlights: Time of turmoil for Georgia hospitals; Oregon Medicaid takes aim at expensive heptatitis C drug

Medicare drug premiums to rise $1 a month in 2015

Researchers one step closer to finding treatment for dengue fever

State highlights: Maryland's top health official leaving for Johns Hopkins; Minnesota lawmakers to propose legislation to require contraception coverage

Cigna's quarterly earnings up

First Edition: July 31, 2014

Several insurers report lower profits

First Edition: July 30, 2014

Conjoint Analysis method can show how important different treatment goals are for respondents

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

New study in recognition of World Hepatitis Day released on Life Sciences Connect

First Edition: July 28, 2014

Researchers provide global genotype prevalence estimates for HCV

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in